Benyard B, Mathur A, Roy D, Swain A, Kohkhar SK, Soni ND, Wilson N, Haris M, Zamani P, Reddy R, Kumar D Dual-Breathing CrCEST: A Novel Imaging Method to Distinguish Oxygen Delivery and Utilization in Exercised Muscle , International Society for Magnetic Resonance in Medicine, Cape Town, South Africa: 2026

Rosenbaum M, Allison KC, Laughlin MR, Kelley SS, Nunez-Matos J, Rickles M, Chau L, Wu G, Zamani P, Whyte KJ, Leibel RL, Hayes MR. The Physiology Of the WEight Reduced State (POWERS) study: strategies for the analysis of biological specimens. , Int J Obes (Lond): 2026

Cohen JB, Hossain A, Chittams J, Zhao M, Afable J, Greenip A, Maynard H, Pourmussa B, Prenner SB, Selvaraj S, Townsend RR, Zamani P, Chirinos JA. Calcium Channel Blockade versus Beta-Blockade for Hypertension in HFpEF: A Randomized Crossover Trial , Accepted for publication in Hypertension, May 2026: 2026

Lin KY, Bucha A, McSweeney K, Wade KL, Karaj A, Tamaroff J, O’Malley S, Chung NM, Cilenti NA, Wanner J, Adzika GK, Mesaros C, Rojsajjakul T, Blair IA, Serai S, Farmer J, Bryant K, Harhay MO, Lu Y, Paridon SM, Weber DR, Seifert W, Putt ME, Zamani P, Baur JA, Lynch DR, McCormack SE. Individualized exercise and NAD+ precursor supplementation in Friedreich’s Ataxia: a randomized controlled trial. , Lancet: Neurology, 25: 2026,469

Vidula MK, Schurgers LJ, Zhao L, Dib MJ, Zhao M, Wang Z, Ebert C, Salman O, Azzo JD, Zamani P, van Empel V, Richards AM, Doughty R, Javaheri A, Mann DL, Rietzschell E, Kammerhoff K, Schafer P, Seiffert DA, Ramirez-Valle F, Cappola TP, Chirinos JA Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure , Circ Heart Fail, 19: 2026,e012734

Vajargah KK, Dib MJ, Tavolinejad H, Zamani P, Richards AM, Mann DL, Rietzschel E, van Empel V, Burgess S, Cappola TP, Chirinos JA. Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction , JACC Heart Fail: 2025,102771

Saw EL, Werner LD, Cooper H, Pimental DR, Zamani P, Chirinos JA, Valero-Muñoz M, Sam F. Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction , Circ Heart Fail, 18(6): 2025,e012350

Selvaraj S, Karaj A, Chirinos JA, Denney N, Grosso G, Fernando M, Chambers K, Demastus C, Reddy R, Langham M, Kumar D, Maynard H, Pourmussa B, Prenner SB, Cohen JB, Ischiropoulos H, Rickels MR, Poole DC, Church DD, Wolfe RR, Kelly DP, Putt M, Margulies KB, Zamani P Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure with Preserved Ejection Fraction , JACC Heart Fail, 13(12): 2025,102435

Zamani P, Shah SJ, Cohen JB, Zhao M, Yang W, Afable JL, Caturla M, Maynard H, Pourmussa B, Demastus C, Mohanty I, Miyake MM, Adusumalli S, Margulies KB, Prenner SB, Poole DC, Wilson N, Reddy R, Townsend RR, Ischiropoulos H, Cappola TP, Chirinos JA Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial , JAMA Cardiol., 10(3): 2025,284

Selvaraj S, Karaj A, Chirinos JA, Denney N, Fernando M, Chambers K, Demastus C, Langham M, Maynard H, Pourmussa B, Prenner SB, Cohen J, Ischiropoulos H, Rickels M, Church D, Wolfe R, Kelly DP, Putt ME, Margulies KB, Zamani P. FUEL UTILIZATION DURING EXERCISE WITH EXOGENOUS KETONES VERSUS PLACEBO IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: KETO-HFPEF , American College of Cardiology Annual Session, March 29-31, 2025; Chicago, IL.: 2025